These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases. Fujisawa T; Hozumi H; Kono M; Enomoto N; Nakamura Y; Inui N; Nakashima R; Imura Y; Mimori T; Suda T Respir Investig; 2017 Mar; 55(2):130-137. PubMed ID: 28274528 [TBL] [Abstract][Full Text] [Related]
4. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Ye S; Chen XX; Lu XY; Wu MF; Deng Y; Huang WQ; Guo Q; Yang CD; Gu YY; Bao CD; Chen SL Clin Rheumatol; 2007 Oct; 26(10):1647-54. PubMed ID: 17308858 [TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases]. Xie MM; Yan X; Li H; Ding JJ; Gui XH; Liu Y; Wang YS; Chen ZY; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug; 41(8):616-621. PubMed ID: 30138971 [No Abstract] [Full Text] [Related]
7. Prognostic factors for myositis-associated interstitial lung disease. Fujisawa T; Hozumi H; Kono M; Enomoto N; Hashimoto D; Nakamura Y; Inui N; Yokomura K; Koshimizu N; Toyoshima M; Shirai T; Yasuda K; Hayakawa H; Suda T PLoS One; 2014; 9(6):e98824. PubMed ID: 24905449 [TBL] [Abstract][Full Text] [Related]
8. Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients. Peng JM; Du B; Wang Q; Weng L; Hu XY; Wu CY; Shi Y PLoS One; 2016; 11(4):e0154441. PubMed ID: 27115138 [TBL] [Abstract][Full Text] [Related]
9. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease. Cobo-Ibáñez T; López-Longo FJ; Joven B; Carreira PE; Muñoz-Fernández S; Maldonado-Romero V; Larena-Grijalba C; Cubas IL; Muriel ET; Mateos CB; de la Peña Lefebvre PG; Gomez-Gomez A; Nogal LB; Pérez A; Almodovar R; Lojo L; Ruiz-Gutiérrez L; López-Robledillo JC; García de Yébenes MJ; Nuño-Nuño L Clin Rheumatol; 2019 Mar; 38(3):803-815. PubMed ID: 30392161 [TBL] [Abstract][Full Text] [Related]
10. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R Arthritis Care Res (Hoboken); 2016 May; 68(5):689-94. PubMed ID: 26414240 [TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease. Go DJ; Park JK; Kang EH; Kwon HM; Lee YJ; Song YW; Lee EB Rheumatol Int; 2016 Jan; 36(1):125-31. PubMed ID: 26223808 [TBL] [Abstract][Full Text] [Related]
13. Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. Yamasaki Y; Yamada H; Ohkubo M; Yamasaki M; Azuma K; Ogawa H; Mizushima M; Ozaki S J Rheumatol; 2011 Aug; 38(8):1636-43. PubMed ID: 21572147 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease in polymyositis and dermatomyositis. Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835 [TBL] [Abstract][Full Text] [Related]
15. HRCT score and serum ferritin level are factors associated to the 1-year mortality of acute interstitial lung disease in clinically amyopathic dermatomyositis patients. Zou J; Guo Q; Chi J; Wu H; Bao C Clin Rheumatol; 2015 Apr; 34(4):707-14. PubMed ID: 25609178 [TBL] [Abstract][Full Text] [Related]
16. The prognostic value of HRCT in myositis-associated interstitial lung disease. Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Aihara K; Ikezoe K; Watanabe K; Taguchi Y; Hatta K; Oga T; Chin K; Nagai S; Mimori T; Mishima M Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580 [TBL] [Abstract][Full Text] [Related]
18. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases]. Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111 [No Abstract] [Full Text] [Related]
20. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy. Bai Z; Shen G; Dong L Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]